(Q48095820)

8 February 2018

title

Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice. (English)

1 reference

8 February 2018

0 references

1 reference

2

D M Holtzman

1 reference

8 February 2018

Anne M Fagan

1

object named as

A M Fagan

1 reference

8 February 2018

author name string

G Munson

3

1 reference

8 February 2018

T Mathur

4

1 reference

8 February 2018

D Schneider

5

1 reference

8 February 2018

L K Chang

6

1 reference

8 February 2018

G S Getz

7

1 reference

8 February 2018

C A Reardon

8

1 reference

8 February 2018

J A Shah

10

1 reference

8 February 2018

M J LaDu

11

1 reference

8 February 2018

J Lukens

9

1 reference

PubMed ID

10514484

8 February 2018

language of work or name

English

0 references

publication date

1 October 1999

1 reference

8 February 2018

Journal of Biological Chemistry

published in

1 reference

8 February 2018

volume

274

1 reference

8 February 2018

page(s)

30001-30007

1 reference

8 February 2018

issue

42

1 reference

8 February 2018

Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

A new low density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Astrocytic messenger RNA responses to striatal deafferentation in male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Seizure activity causes a rapid increase in sulfated glycoprotein-2 messenger RNA in the adult but not the neonatal rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

SP-40,40 is a constituent of Alzheimer's amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Biology of A beta amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Purification and characterization of brain clusterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Lipoprotein-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Apolipoprotein J: structure and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Apolipoproteins in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Characterization of apolipoprotein J-Alzheimer's A beta interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Electron microscopy of negatively stained lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Phospholipid transfer protein can transform reconstituted discoidal HDL into vesicular structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Expression of apolipoprotein E mRNA in rat microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.42.30001

21 January 2018

Identifiers

DOI

10.1074/JBC.274.42.30001

1 reference

8 February 2018

PubMed ID

10514484

1 reference

8 February 2018